Higher CEA levels in patients with colorectal cancer are indicative of aggressive tumour phenotypes and survival Evidence ...

“Our new biochip device is low-cost — just a few dollars — and sensitive, which will make accurate disease diagnosis ...

Researchers reveal how a new breakthrough could make early cancer detection more accessible and affordable worldwide.

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during ...

In contrast, tests involving other cancer markers, such as carcinoembryonic antigen and carbohydrate antigen 19-9, generally cannot reach the high sensitivity needed for catching early-stage cancers.

Carcinoembryonic antigen; QD: Quantum dot. This work has been funded by a grant from Yousef Jameel (YJ-Science & Technology Research Center, The American University in Cairo) to H Azzazy.

Pancreaticobiliary cytopathology has emerged as a critical diagnostic tool, especially in evaluating pancreatic and bile duct lesions. Traditionally ...

The efficacy seen in a small study, especially in GNAS-mutated tumors, could influence care, but the rarity of the cancer is ...

Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...